Avenue Therapeutics, Inc. - ATXI

SEC FilingsOur ATXI Tweets

About Gravity Analytica

Recent News

  • 12.05.2025 - DEF 14A - Definitive proxy statements
  • 11.18.2025 - 8-K - Current report
  • 11.13.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
  • 11.12.2025 - 8-K - Current report
  • 08.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
  • 07.18.2025 - 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  • 05.15.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
  • 04.30.2025 - 8-K - Current report
  • 04.02.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
  • 04.02.2025 - 4 - Statement of changes in beneficial ownership of securities

Recent Filings

  • 11.18.2025 - 8-K Current report
  • 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 11.12.2025 - EX-99.1 EX-99.1
  • 11.12.2025 - 8-K Current report
  • 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 07.18.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  • 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 04.30.2025 - 8-K Current report
  • 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.02.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership